• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Analysis of the expression of human tumor antigens in ovarian cancer tissues.分析人肿瘤抗原在卵巢癌组织中的表达。
Cancer Biomark. 2010;6(1):33-48. doi: 10.3233/CBM-2009-0117.
2
Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer.在低级别上皮性卵巢癌中,MRE11-RAD50-NBS1(MRN)复合物检测缺失频繁出现。
BMC Cancer. 2017 Jan 10;17(1):44. doi: 10.1186/s12885-016-3026-2.
3
RAD50/MRE11/NBS1 proteins in relation to tumour development and prognosis in patients with microsatellite stable colorectal cancer.RAD50/MRE11/NBS1蛋白与微卫星稳定型结直肠癌患者肿瘤发生及预后的关系
Histol Histopathol. 2008 Dec;23(12):1495-502. doi: 10.14670/HH-23.1495.
4
Clinical relevance of TAp73 and ΔNp73 protein expression in ovarian cancer: a series of 83 cases and review of the literature.TAp73 和 ΔNp73 蛋白在卵巢癌中的表达的临床相关性:一系列 83 例病例及文献复习。
Int J Gynecol Pathol. 2011 Nov;30(6):527-31. doi: 10.1097/PGP.0b013e31821ac519.
5
Clinical and prognostic significance of lost or decreased PDCD5 expression in human epithelial ovarian carcinomas.人卵巢上皮性癌中 PDCD5 表达缺失或降低的临床及预后意义。
Oncol Rep. 2011 Feb;25(2):353-8. doi: 10.3892/or.2010.1103. Epub 2010 Dec 13.
6
Overexpression of p21WAF1/CIP1 and MDM2 characterizes serous borderline ovarian tumors.p21WAF1/CIP1和MDM2的过表达是浆液性交界性卵巢肿瘤的特征。
Hum Pathol. 2000 Jun;31(6):698-704. doi: 10.1053/hupa.2000.7641.
7
P73 gene expression in ovarian cancer tissues and cell lines.P73基因在卵巢癌组织及细胞系中的表达。
Clin Cancer Res. 2000 Oct;6(10):3910-5.
8
Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays.通过高通量抗原克隆和阵列检测确定的卵巢癌诊断标志物
Cancer Res. 2006 Jan 15;66(2):1181-90. doi: 10.1158/0008-5472.CAN-04-2962.
9
Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study.精子蛋白 17 作为上皮性卵巢癌肿瘤标志物的有效性和预后意义:一项回顾性研究。
BMC Cancer. 2018 Oct 11;18(1):970. doi: 10.1186/s12885-018-4880-x.
10
Alpha(v)beta(6) integrin-A marker for the malignant potential of epithelial ovarian cancer.α(v)β(6)整合素——上皮性卵巢癌恶性潜能的标志物
J Histochem Cytochem. 2002 Oct;50(10):1371-80. doi: 10.1177/002215540205001010.

引用本文的文献

1
NASP modulates histone turnover to drive PARP inhibitor resistance.核仁自体磷酸化蛋白(NASP)调节组蛋白周转以驱动聚(ADP-核糖)聚合酶(PARP)抑制剂耐药。
Nature. 2025 Aug 13. doi: 10.1038/s41586-025-09414-z.
2
Initiation and elongation factor co-expression correlates with recurrence and survival in epithelial ovarian cancer.启动和延伸因子共表达与上皮性卵巢癌的复发和生存相关。
J Ovarian Res. 2022 Jun 19;15(1):73. doi: 10.1186/s13048-022-00998-y.
3
Knockdown of long noncoding RNA colorectal neoplasia differentially expressed inhibits hepatocellular carcinoma progression by mediating the expression of nuclear autoantigenic sperm protein.长链非编码 RNA 结直肠肿瘤差异表达的敲低通过介导核自身抗原精子蛋白的表达抑制肝细胞癌进展。
Oncol Rep. 2021 Dec;46(6). doi: 10.3892/or.2021.8203. Epub 2021 Oct 11.
4
Identification of the Role and Clinical Prognostic Value of Target Genes of m6A RNA Methylation Regulators in Glioma.m6A RNA甲基化调节剂靶基因在胶质瘤中的作用及临床预后价值的鉴定
Front Cell Dev Biol. 2021 Sep 13;9:709022. doi: 10.3389/fcell.2021.709022. eCollection 2021.
5
Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer.在低级别上皮性卵巢癌中,MRE11-RAD50-NBS1(MRN)复合物检测缺失频繁出现。
BMC Cancer. 2017 Jan 10;17(1):44. doi: 10.1186/s12885-016-3026-2.
6
Unraveling molecular effects of ADAR1 overexpression in HEK293T cells by label-free quantitative proteomics.通过无标记定量蛋白质组学揭示ADAR1在HEK293T细胞中过表达的分子效应
Cell Cycle. 2016 Jun 17;15(12):1591-601. doi: 10.1080/15384101.2016.1176657. Epub 2016 Apr 22.
7
Molecular evolution of NASP and conserved histone H3/H4 transport pathway.NASP 分子进化与保守的组蛋白 H3/H4 运输途径。
BMC Evol Biol. 2014 Jun 20;14:139. doi: 10.1186/1471-2148-14-139.
8
Serum prognostic biomarkers in head and neck cancer patients.头颈部癌症患者的血清预后生物标志物。
Laryngoscope. 2014 Aug;124(8):1819-26. doi: 10.1002/lary.24567. Epub 2014 Jan 29.
9
Expression of Tra2 β in Cancer Cells as a Potential Contributory Factor to Neoplasia and Metastasis.癌细胞中Tra2β的表达作为肿瘤形成和转移的潜在促成因素。
Int J Cell Biol. 2013;2013:843781. doi: 10.1155/2013/843781. Epub 2013 Jul 8.
10
Autoantibodies as biomarkers for ovarian cancer.自身抗体作为卵巢癌的生物标志物。
Cancer Biomark. 2010;8(4-5):187-201. doi: 10.3233/CBM-2011-0213.

本文引用的文献

1
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).多模式及超声筛查卵巢癌的敏感性和特异性,以及所检测癌症的分期分布:英国卵巢癌筛查协作试验(UKCTOCS)患病率筛查结果
Lancet Oncol. 2009 Apr;10(4):327-40. doi: 10.1016/S1470-2045(09)70026-9. Epub 2009 Mar 11.
2
Alternative isoform regulation in human tissue transcriptomes.人类组织转录组中的可变亚型调控
Nature. 2008 Nov 27;456(7221):470-6. doi: 10.1038/nature07509.
3
Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunity.乳腺癌中HER-2/neu蛋白的表达水平可能会影响内源性HER-2/neu特异性免疫的发展。
Mol Cancer Ther. 2008 Mar;7(3):449-54. doi: 10.1158/1535-7163.MCT-07-0386. Epub 2008 Mar 4.
4
Clinical significance of RCAS1 as a biomarker of ovarian cancer.RCAS1作为卵巢癌生物标志物的临床意义。
Oncol Rep. 2007 Mar;17(3):623-8.
5
Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas.缺氧诱导因子1α在I型和II型子宫内膜癌中的表达增加。
Mod Pathol. 2007 Jan;20(1):35-43. doi: 10.1038/modpathol.3800718. Epub 2006 Nov 10.
6
TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells.TSPY通过促进HeLa细胞和NIH3T3细胞的细胞周期进程来增强细胞增殖和肿瘤发生。
BMC Cancer. 2006 Jun 9;6:154. doi: 10.1186/1471-2407-6-154.
7
Nuclear autoantigenic sperm protein (NASP), a linker histone chaperone that is required for cell proliferation.核自身抗原性精子蛋白(NASP),一种细胞增殖所必需的连接组蛋白伴侣。
J Biol Chem. 2006 Jul 28;281(30):21526-21534. doi: 10.1074/jbc.M603816200. Epub 2006 May 25.
8
Cancer statistics, 2006.2006年癌症统计数据。
CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30. doi: 10.3322/canjclin.56.2.106.
9
Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays.通过高通量抗原克隆和阵列检测确定的卵巢癌诊断标志物
Cancer Res. 2006 Jan 15;66(2):1181-90. doi: 10.1158/0008-5472.CAN-04-2962.
10
Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens.Epitomics:使用肿瘤抗原复合检测板通过微阵列进行血清筛查以早期检测癌症。
Expert Rev Mol Diagn. 2005 Sep;5(5):735-43. doi: 10.1586/14737159.5.5.735.

分析人肿瘤抗原在卵巢癌组织中的表达。

Analysis of the expression of human tumor antigens in ovarian cancer tissues.

机构信息

Department of Pathology, Wayne State University School of Medicine, Detroit, MI 48201, USA.

出版信息

Cancer Biomark. 2010;6(1):33-48. doi: 10.3233/CBM-2009-0117.

DOI:10.3233/CBM-2009-0117
PMID:20164540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3343030/
Abstract

Biomarkers for early detection of cancer have great clinical diagnostic potential. Numerous reports have documented the generation of humoral immune responses that are triggered in response to changes in protein expression patterns in tumor tissues and these biomarkers are referred to as tumor associated antigens (TAAs). Using a high-throughput technology, we previously identified 65 proteins as diagnostically useful TAAs by profiling the humoral immune responses in ovarian cancer (OVCA) patients. Here we determined the expression status of some of those TAAs in tissues from OVCA patients. The protein expression patterns of 4 of those 65 antigens, namely NASP, RCAS1, Nijmegen breakage syndrome1 (NBS1) and eIF5A, along with p53 and Her2 (known molecular prognosticators) and two proteins that interact with NBS1, MRE11 and RAD50, were assessed by immunohistochemistry (IHC). NASP and RCAS1 proteins were more frequently expressed in ovarian cancer tissues than with normal ovarian tissue and serous cystadenomas and MRE11 was less frequently expressed. When evaluated simultaneously, only NASP and MRE11 remained statistically significant with sensitivity of 66% and specificity of 89%. None of these proteins' expression levels were prognostic for survival. Together, our results indicate that occurrence of humoral immune responses against some of these TAAs in OVCA patients is triggered by antigen protein overexpression.

摘要

用于癌症早期检测的生物标志物具有很大的临床诊断潜力。大量报告记录了体液免疫应答的产生,这些应答是针对肿瘤组织中蛋白质表达模式的变化而触发的,这些生物标志物被称为肿瘤相关抗原(TAA)。我们之前使用高通量技术,通过分析卵巢癌(OVCA)患者的体液免疫反应,鉴定了 65 种具有诊断意义的 TAA。在此,我们确定了其中一些 TAA 在 OVCA 患者组织中的表达状态。通过免疫组织化学(IHC)评估了其中 4 种 TAA 的蛋白表达模式,即 NASP、RCAS1、Nijmegen 断裂综合征 1(NBS1)和 eIF5A,以及 p53 和 Her2(已知的分子预后标志物)和与 NBS1 相互作用的两种蛋白质,即 MRE11 和 RAD50。NASP 和 RCAS1 蛋白在卵巢癌组织中的表达频率高于正常卵巢组织和浆液性囊腺瘤,而 MRE11 的表达频率较低。同时评估时,只有 NASP 和 MRE11 仍然具有统计学意义,敏感性为 66%,特异性为 89%。这些蛋白质的表达水平均与生存无关。总之,我们的结果表明,OVCA 患者中针对这些 TAA 中的一些发生体液免疫应答是由抗原蛋白过表达触发的。